212 related articles for article (PubMed ID: 38663958)
1. Importance of targeting various cell signaling pathways in solid cancers.
Ghosh C; Hu J
Int Rev Cell Mol Biol; 2024; 385():101-155. PubMed ID: 38663958
[TBL] [Abstract][Full Text] [Related]
2. Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis.
Iqbal W; Alkarim S; AlHejin A; Mukhtar H; Saini KS
Oncotarget; 2016 Nov; 7(46):76337-76353. PubMed ID: 27486983
[TBL] [Abstract][Full Text] [Related]
3. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic approaches targeting cancer stem cells.
Pan Y; Ma S; Cao K; Zhou S; Zhao A; Li M; Qian F; Zhu C
J Cancer Res Ther; 2018; 14(7):1469-1475. PubMed ID: 30589025
[TBL] [Abstract][Full Text] [Related]
5. Mapping the Pathways of Resistance to Targeted Therapies.
Wood KC
Cancer Res; 2015 Oct; 75(20):4247-51. PubMed ID: 26392071
[TBL] [Abstract][Full Text] [Related]
6. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
Yan Y; Zuo X; Wei D
Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
[TBL] [Abstract][Full Text] [Related]
7. Molecular Targets, Anti-cancer Properties and Potency of Synthetic Indole-3-carbinol Derivatives.
Karimabad MN; Mahmoodi M; Jafarzadeh A; Darekordi A; Hajizadeh MR; Hassanshahi G
Mini Rev Med Chem; 2019; 19(7):540-554. PubMed ID: 30444199
[TBL] [Abstract][Full Text] [Related]
8. Targeting Developmental Pathways: The Achilles Heel of Cancer?
Dempke WCM; Fenchel K; Uciechowski P; Chevassut T
Oncology; 2017; 93(4):213-223. PubMed ID: 28738360
[TBL] [Abstract][Full Text] [Related]
9. Precision medicine for human cancers with Notch signaling dysregulation (Review).
Katoh M; Katoh M
Int J Mol Med; 2020 Feb; 45(2):279-297. PubMed ID: 31894255
[TBL] [Abstract][Full Text] [Related]
10. Cancer and Apoptosis.
Chaudhry GE; Akim AM; Sung YY; Muhammad TST
Methods Mol Biol; 2022; 2543():191-210. PubMed ID: 36087269
[TBL] [Abstract][Full Text] [Related]
11. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
12. Novel Therapeutics Against Breast Cancer Stem Cells by Targeting Surface Markers and Signaling Pathways.
Das PK; Rakib MA; Khanam JA; Pillai S; Islam F
Curr Stem Cell Res Ther; 2019; 14(8):669-682. PubMed ID: 31808385
[TBL] [Abstract][Full Text] [Related]
13. S1PR1 as a Novel Promising Therapeutic Target in Cancer Therapy.
Rostami N; Nikkhoo A; Ajjoolabady A; Azizi G; Hojjat-Farsangi M; Ghalamfarsa G; Yousefi B; Yousefi M; Jadidi-Niaragh F
Mol Diagn Ther; 2019 Aug; 23(4):467-487. PubMed ID: 31115798
[TBL] [Abstract][Full Text] [Related]
14. Insights into new mechanisms and models of cancer stem cell multidrug resistance.
Garcia-Mayea Y; Mir C; Masson F; Paciucci R; LLeonart ME
Semin Cancer Biol; 2020 Feb; 60():166-180. PubMed ID: 31369817
[TBL] [Abstract][Full Text] [Related]
15. Cancer stem cells: implications for cancer therapy.
Dawood S; Austin L; Cristofanilli M
Oncology (Williston Park); 2014 Dec; 28(12):1101-7, 1110. PubMed ID: 25510809
[TBL] [Abstract][Full Text] [Related]
16. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.
Sabbah M; Emami S; Redeuilh G; Julien S; Prévost G; Zimber A; Ouelaa R; Bracke M; De Wever O; Gespach C
Drug Resist Updat; 2008; 11(4-5):123-51. PubMed ID: 18718806
[TBL] [Abstract][Full Text] [Related]
17. Molecular and clinical significance of fibroblast growth factor 2 (FGF2 /bFGF) in malignancies of solid and hematological cancers for personalized therapies.
Akl MR; Nagpal P; Ayoub NM; Tai B; Prabhu SA; Capac CM; Gliksman M; Goy A; Suh KS
Oncotarget; 2016 Jul; 7(28):44735-44762. PubMed ID: 27007053
[TBL] [Abstract][Full Text] [Related]
18. Cancer stem cells: biological functions and therapeutically targeting.
Ciurea ME; Georgescu AM; Purcaru SO; Artene SA; Emami GH; Boldeanu MV; Tache DE; Dricu A
Int J Mol Sci; 2014 May; 15(5):8169-85. PubMed ID: 24821540
[TBL] [Abstract][Full Text] [Related]
19. Targeting Cancer Stemness in the Clinic: From Hype to Hope.
Saygin C; Matei D; Majeti R; Reizes O; Lathia JD
Cell Stem Cell; 2019 Jan; 24(1):25-40. PubMed ID: 30595497
[TBL] [Abstract][Full Text] [Related]
20. Targeting PI3K Signaling in Combination Cancer Therapy.
Pons-Tostivint E; Thibault B; Guillermet-Guibert J
Trends Cancer; 2017 Jun; 3(6):454-469. PubMed ID: 28718419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
